top of page
Search

Apr 02, 2021

Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its Abbreviated New Drug Application for Fluocinolone Acetonide Topical Oil, 0.01% (Body Oil) in 118.28 mL bottle a generic version of reference listed drug DERMA-SMOOTHE/FS. For more updates, please visit the products page or email us directly at info@solaris-pharma.com

81 views0 comments

Recent Posts

See All

Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its Abbreviated New Drug Application for Clindamycin Phosphate Gel USP

Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its Abbreviated New Drug Application for Fluocinolone Acetonide Oil, 0

bottom of page